ESC Premium Access

Twelve versus 30 month dual antiplatelet therapy after percutaneous coronary intervention using national health insurance review & assessment (HIRA) database

Congress Presentation

About the speaker

Associate Professor Victor L Serebruany

Johns Hopkins University of Baltimore, Baltimore (United States of America)
2 presentations
0 follower

18 more presentations in this session

Eight-year clinical outcome of sirolimus-eluting stent implantation for small vessel disease

Speaker: Doctor M. Miura (Tokyo, JP)


Paclitaxel- versus zotarolimus-eluting stents in diffuse coronary artery disease; 3-year clinical cutcomes

Speaker: Doctor J. Ahn (Deajeon, KR)


Effect of diameter of drug-eluting stents versus bare-metal stents on late outcomes: a propensity score-matched analysis

Speaker: Doctor A. Levi (Petah Tikva, IL)


Long-term clinical outcomes of complete versus partial stent fracture after second-generation drug-eluting stent implantation

Speaker: Associate Professor D. Kim (Gimhae-si, KR)


Long-term clinical impact of stent fracture on second generation drug-eluting stent in comparison with first generation drug-eluting stent

Speaker: Doctor M. Ohya (Kurashiki, JP)


Access the full session

Poster session 4 - Impact of stent design on post PCI outcomes

Speakers: Associate Professor V. Serebruany, Doctor M. Miura, Doctor J. Ahn, Doctor A. Levi, Associate Professor D. Kim...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb